B Vitamins help halt Alzheimer’s

FT.com / UK - Vitamin B claim on Alzheimer’s: Save this - as you may not hear this information again.

It's long been known amongst nutritionists of the detrimental effects of elevated homocysteine levels on heart health and the nervous system. It's also known that the solution is simple - putting back the B vitamins that are refined and processed out of the modern diet.

See this trial

Results

A total of 168 participants (85 in active treatment group; 83 receiving placebo) completed the MRI section of the trial. The mean rate of brain atrophy per year was 0.76% [95% CI, 0.63–0.90] in the active treatment group and 1.08% [0.94–1.22] in the placebo group (P = 0.001). The treatment response was related to baseline homocysteine levels: the rate of atrophy in participants with homocysteine >13 µmol/L was 53% lower in the active treatment group (P = 0.001). A greater rate of atrophy was associated with a lower final cognitive test scores. There was no difference in serious adverse events according to treatment category.

Conclusions and Significance

The accelerated rate of brain atrophy in elderly with mild cognitive impairment can be slowed by treatment with homocysteine-lowering B vitamins. Sixteen percent of those over 70 y old have mild cognitive impairment and half of these develop Alzheimer's disease. Since accelerated brain atrophy is a characteristic of subjects with mild cognitive impairment who convert to Alzheimer's disease, trials are needed to see if the same treatment will delay the development of Alzheimer's disease.


The Solution is Too Simple

“The dogma is strong (amongst Alzheimer’s research community) and there is money involved,” said Professor Smith, one of the authors. “If it is not produced by the pharmaceutical companies, you have a hard time getting funded.”